Kiniksa Pharmaceuticals International (KNSA) Non-Current Deffered Revenue (2022 - 2026)
Kiniksa Pharmaceuticals International's Non-Current Deffered Revenue was $31.81 million in Q2 2026, unchanged from $31.81 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Non-Current Deffered Revenue (2022 - 2026) Analysis & Trends
From Q1 2022 onward, Kiniksa Pharmaceuticals International has reported Non-Current Deffered Revenue for 18 quarters.
- Non-Current Deffered Revenue shows a three-year compound annual growth rate of 38.4% (FY2022 to FY2025).
- In earlier years, Non-Current Deffered Revenue was $31.81 million in FY2024 (+166.1%), $11.95 million in FY2023 (-0.4%) and $12 million in FY2022.
- Compared with a year earlier, Non-Current Deffered Revenue was higher in four of the last eight quarters, with growth averaging 84.2%.
- The best year-over-year quarter for Non-Current Deffered Revenue over five years was Q2 2025 (growth of 169.6%); the worst was Q3 2023 (a decline of 16.4%).
- Per Business Quant data, KNSA's Non-Current Deffered Revenue in the three quarters before Q2 2026 was $31.81 million (Q1 2026), $31.81 million (Q4 2025) and $31.81 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Kiniksa Pharmaceuticals International | 11.64 Bn | 10.38 Bn | 220.03 Mn | 31.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.81 Mn |
| Mar 31, 2026 | 31.81 Mn |
| Dec 31, 2025 | 31.81 Mn |
| Sep 30, 2025 | 31.81 Mn |
| Jun 30, 2025 | 31.81 Mn |
| Mar 31, 2025 | 31.81 Mn |
| Dec 31, 2024 | 31.81 Mn |
| Sep 30, 2024 | 11.81 Mn |
| Jun 30, 2024 | 11.80 Mn |
| Mar 31, 2024 | 11.81 Mn |
| Dec 31, 2023 | 11.95 Mn |
| Sep 30, 2023 | 11.87 Mn |
| Jun 30, 2023 | 12.01 Mn |
| Mar 31, 2023 | 12.16 Mn |
| Dec 31, 2022 | 12.00 Mn |
| Sep 30, 2022 | 14.20 Mn |
| Jun 30, 2022 | 12.00 Mn |
| Mar 31, 2022 | 12.00 Mn |
API Access
Kiniksa Pharmaceuticals International Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();